Indian drug makers end generic bids
blackboard1965 / Shutterstock.com
Médecins Sans Frontières (MSF) has urged the Indian Patent Office (IPO) to reject a Gilead Sciences patent application covering Sovaldi (sofosbuvir).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Médecins Sans Frontières; MSF; Indian Patent Office; Gilead Sciences; hepatitis C; I-MAK; Sovaldi; sofosbuvir